WuXi AppTec Launches South Korea Branch
Mar 25, 2016
Seoul, March 25, 2016 – WuXi AppTec (WuXi), a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology and medical device industries, today announced the opening of its branch office in Seoul, South Korea, one of the most dynamic life science innovation hubs in the Asia Pacific region.
Located at an industrial park in the Pangyo Techno Valley, WuXi AppTec Korea branch will help bring WuXi’s comprehensive platform of integrated enabling capabilities closer to the life science community in South Korea. It will also help accelerate the development and commercialization of innovative healthcare products from the region for China and the rest of the world through WuXi’s global expertise and global resources. It is the latest addition to WuXi’s global footprint of 5 million square feet of facility space across 23 sites and offices worldwide.
“We are excited to open an office in South Korea where cutting-edge science is being done,” said Dr. Ge Li, Chairman and CEO of WuXi AppTec, “Our mission is to help entrepreneurs globally to realize their dreams of discovering and developing innovative products to benefit the world's patients."
“WuXi Korea will help provide more tailored-made services to further enable the thriving R&D innovation in the region,” said Dr. Suk Young Cho, General Manager of WuXi AppTec Korea, “We also want to serve as a gateway to help bring more Korea’s innovative healthcare products to patients in China, and around the world.”
About WuXi AppTec
WuXi AppTec is a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States. As a research-driven and customer-focused company, WuXi AppTec provides a broad and integrated portfolio of services throughout the drug and medical device R&D process. WuXi AppTec is also building a platform to provide clinical diagnostic services directly to physicians and their patients globally. WuXi AppTec's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. For more information, please visit: http://www.wuxiapptec.com.
For further information, please contact:
Director of Corporate Communications